GlassScriptPhysician profile
Evelyn B Serrano
NPI 1619167863
$7,299.88
in general payments reported to CMS, 2019-2025
48 companies · $516 in 2025
The $516 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $784 · 2020: $3,242 · 2021: $635 · 2022: $713 · 2023: $780 · 2024: $630 · 2025: $516.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,603.00 | 2019-2024 | |
| Abbvie INC. | $398.53 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $358.29 | 2019-2025 | Aptima, Thinprep 2000 Processor, Acessa Provu System |
| Myovant Sciences INC. | $247.42 | 2021-2022 | |
| Astellas Pharma US INC | $209.48 | 2022-2025 | Veozah |
| Sage Therapeutics, LLC | $173.47 | 2021-2025 | Zurzuvae |
| Gynesonics, INC. | $137.16 | 2022 | |
| Amgen INC. | $129.64 | 2019-2025 | Evenity, Prolia |
| Therapeuticsmd, INC. | $119.15 | 2019-2022 | |
| Myriad Women'S Health, INC. | $115.30 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $112.96 | 2019-2025 | |
| Coloplast Corp | $100.88 | 2021-2025 | |
| Pfizer INC. | $99.78 | 2021-2024 | |
| Ethicon US, LLC | $99.24 | 2023-2025 | Vistaseal, Stratafix, Ethicon |
| Sumitomo Pharma America, INC. | $97.65 | 2023-2025 | Myfembree |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $87.23 | 2020-2023 | Injectafer |
| Millicent US INC | $85.54 | 2024-2025 | Intrarosa, Femlyv |
| Organon LLC | $74.32 | 2022-2025 | Nexplanon, Jada System |
| Vertical Pharmaceuticals, LLC | $72.74 | 2019 | |
| Coopersurgical, INC. | $70.56 | 2019-2022 | |
| Baxter Healthcare | $59.45 | 2023 | Tisseel |
| Mayne Pharma Commercial LLC | $59.23 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $57.16 | 2019-2025 | Gardasil 9 |
| Mylan Pharmaceuticals INC. | $50.60 | 2020-2022 | |
| Dysis Medical, INC. | $44.71 | 2020 | |
| Lupin INC. | $43.23 | 2020-2021 | |
| Monaghan Medical Corporation | $43.09 | 2023-2024 | Aerochamber |
| Agile Therapeutics, INC. | $42.08 | 2021-2023 | Twirla |
| Northgate Technologies, INC. | $41.01 | 2023-2024 | Nti Branded Other (Nti), Smoke Removal -Nebulae Srs |
| Radius Health, INC. | $39.48 | 2023 | Tymlos |
| Boston Scientific Corporation | $34.05 | 2021-2023 | |
| Evofem Biosciences, INC. | $34.05 | 2021 | |
| Ascend Therapeutics US, LLC | $32.82 | 2022-2024 | |
| Covidien LP | $29.05 | 2019 | |
| Exeltis, USA INC. | $28.01 | 2020-2023 | Slynd |
| Meditrina | $27.87 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $27.69 | 2025 | Qelbree |
| Medtronic, INC. | $26.81 | 2023 | Truclear |
| Duchesnay USA Incorporated | $24.39 | 2019 | |
| Channel Medsystems, INC. | $23.22 | 2023 | |
| Abbott Laboratories | $21.59 | 2023 | Freestyle Libre 3 |
| Optumhealth Care Solutions, LLC | $19.72 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Biohaven Pharmaceuticals, INC. | $19.70 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $18.60 | 2023 | Vivjoa |
| Exact Sciences Corporation | $16.69 | 2025 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $15.58 | 2023 | Exparel |
| Avion Pharmaceuticals | $14.47 | 2019 | |
| Radiometer America, INC | $13.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evelyn Serrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.